Hereditary cancer
2 papers
Funding
3 grants since 2024National Cancer InstituteUS$3mNational Human Genome Research InstituteUS$790.6k
Democratizing Detection of Hereditary Cancer Syndromes (2DETECT)
National Cancer InstituteUniversity of UtahUS$2.3m2026–2031
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
National Human Genome Research InstituteNest GenomicsUS$790.6k2024–2027
Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes
National Cancer InstituteHealthPartners InstituteUS$648.2k2024–2029
Latest
13 in 12 monthsProblemy Sotsial'noi Gigieny, Zdravookhraneniia I Istorii Meditsiny
IMPLEMENTATION OF A DYNAMIC SURVEILLANCE PROGRAM FOR EARLY CANCER DETECTION IN HEALTHY INDIVIDUALS CARRYING PATHOGENIC VARIANTS
Study of 986 peopleCancer
Japanese Journal of Clinical Oncology
Interpreting TP53 pathogenic variants in germline testing and cancer genomics: pathogenicity, origin, and clinical actionability
ReviewCancer
Research Square
Rethinking Hereditary Cancer Testing Eligibility: A Five-Domain Framework Beyond Family History Gating
Preprint: systematic review of observational studiesIndustry & policy
JHEP Reports
Multi-ancestry sequencing analysis in 293,141 participants identifies predisposition DNA repair genes associated with HCC risk
Case-control study of 290,547 peopleBiomarkers
JAMA Network Open
A Multilevel Intervention to Identify Individuals for Genetic Testing and Treatment: The IGNITE-TX Pilot Randomized Clinical Trial
Randomised trial in peopleInterventions
European Journal of Endocrinology
Low-frequency CDKN1B variants in pituitary testing: a diagnostic pitfall
Case series of 3 peopleMechanisms
Cancer Research Communications
Community-Based Hereditary Breast and Ovarian Cancer Family History Assessment and Genetic Testing among Spanish-Speaking Hispanic/Latina Women in California
Cohort study of 1,286 peopleOvarian cancer